Novo Nordisk, Hims & Hers settle GLP-1 drug dispute Kimberly Redmond 9, 2026// The basics: Novo Nordisk, Hims & Hers resolve GLP-1 drug lawsuit Wegovy, Ozempic to be offered on Hims & Hers platform Hims & Hers agrees to stop selling compounded semaglutide FDA-backed deal expands access to approved weight-loss drugs Novo Nordisk and Hims & Hers have ended a legal feud with an agreement that allows the telehealth platform to sell the pharma giants blockbuster brand-name GLP-1 drugs
But the degree of blood sugar improvement differs substantially
This result is similar to others in pancreatic cells, which are reported to express glucagon receptors and GIP receptors as well as GLP-1R, whereas cells express glucagon and GIP receptors, but no GLP-1Rs
It's important to remain vigilant for symptoms of biliary complications such as jaundice (yellowing of skin/eyes), dark urine, or pale stools, as GLP-1 receptor agonists can increase the risk of biliary events even in those without a gallbladder
5-Amino-1MQ is a peptide classified as an NNMT (Nicotinamide N-methyltransferase) inhibitor
